by Dr Robbins | Mar 11, 2010 | Headache Drugs
Researchers believe they know why light exacerbates the already debilitating pain of migraines, even in some blind people. A report published in Nature Neuroscience reveals how visual and pain pathways in the brain converge to produce this phenomenon. The Boston-based...
by Dr Robbins | Mar 4, 2010 | Headache Drugs
The pharmacologic treatment of migraine may be acute (abortive) or preventive (prophylactic), and patients with frequent severe headaches often require both approaches. Preventive therapy is used to try to reduce the frequency, duration, or severity of attacks. The...
by Dr Robbins | Mar 4, 2010 | Headache Drugs
Children and adolescents experience headaches as do adults and usually present with migraine and chronic daily or tension-type headaches. As some adolescents are unable to achieve headache relief after various treatment strategies, botulinum toxin type A (Botox)...
by Dr Robbins | Mar 4, 2010 | Headache Drugs
Migraine is a common and disabling brain disorder with a strong inherited component. Because patients with migraine have severe and disabling attacks usually of headache with other symptoms of sensory disturbance (eg, light and sound sensitivity), medical treatment...
by Dr Robbins | Feb 26, 2010 | Headache Drugs
Chronic daily headache (CDH) is a common problem, affecting approximately 3 to 4% of the population. CDH poses a significant therapeutic challenge to both physician and patient. For those with moderate or severe CDH, preventive medications are often utilized in an...
by Dr Robbins | Feb 24, 2010 | Headache Drugs
Migraine with and without aura is associated with an increased risk of both cardiovascular disease (CVD) and risk factors for CVD, according to an analysis of data from the American Migraine Prevalence and Prevention study. In an accompanying editorial, Dr....
